Multiple Sclerosis: Archives News of the month
Understanding Depression in People Living with Multiple Sclerosis: A Narrative Review of Recent Literature
Multiple Sclerosis 10 min.
Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease that affects nearly 1 million adults in the US [1]. Psychologic disorders are common comorbidities in people with MS (pwMS), with depression (including symptoms of and diagnosable clinical depression) among the most common...
The prevalence of sexual dysfunction and its contributors among the women with multiple sclerosis
Multiple Sclerosis 3 min.
Multiple Sclerosis is an auto-immune disease in which the nerve fibers are attacked by the immune system and are demyelinated [1]. As a result, the speed of nervous control is decreased and consequently, it leads to permanent disability of the central nervous system [1]. Over 2.5 million people...
Experiences and challenges of people with multiple sclerosis and low attendance to clinical follow-up: a qualitative study
Multiple Sclerosis 8 min.
2.8 million people are living with Multiple Sclerosis (MS) worldwide, and Denmark currently has the highest incidence, with around 700 people diagnosed with MS annually [1, 2–3]. MS is a chronic autoimmune disease affecting the central nervous system, where inflammation, demyelination, and...
Effect of expressive writing on the sexual self-concept in men with multiple sclerosis: a randomized clinical controlled trial
Multiple Sclerosis 4 min.
Multiple sclerosis (MS) is a common chronic neurodegenerative disease of the central nervous system, leading to neurological disability, particularly in young adults [1]. It affects 2.8 million cases worldwide [2]. In Iran, the number of people with MS was approximately 89,000 in 2021 and continues...
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France
Multiple Sclerosis 8 min.
Dimethyl fumarate (DMF; Tecfidera; Biogen, Cambridge, MA, USA), a disease-modifying therapy (DMT), is indicated in patients with relapsing-remitting multiple sclerosis (RRMS) [1]. Significant, clinically meaningful, sustained efficacy and a favorable benefit-risk profile for DMF have been demonstrated...
